Resultaten visas 1 - 10 / 233
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2020.1761229
Cervera-Carrascon, Victor; Quixabeira, Dafne C.A.; Santos, Joao Manuel ; Havunen, Riikka; Zafar, S...
Oncoimmunology2020Publicationer information ikon

Oncolytic Adenoviruses for Cancer Therapy

Referentgranskad
Öppen tillgång
DOI
10.3390/ijms22052517
Tripodi, Lorella; Vitale, Maria; Cerullo, Vincenzo; Pastore, Lucio
International Journal of Molecular Sciences2021Publicationer information ikon

Selective replication of miR-145-regulated oncolytic adenovirus in MCF-7 breast cancer cells

Referentgranskad
DOI
10.2217/fvl-2016-0069
Shayestehpour, Mohammad; Moghim, Sharareh; Salimi, Vahid; Jalilvand, Somayeh; Yavarian, Jila; Romani...
Future virology2016Publicationer information ikon

Mechanistic insights into oncolytic adenovirus therapy

Öppen tillgång
Heiniö, Camilla
Dissertationes scholae doctoralis ad sanitatem investigandam Universitatis Helsinkiensis2023Publicationer information ikon

Oncolytic adenovirus based on serotype 3

Referentgranskad
DOI
10.1038/cgt.2010.79
Hemminki, O.; Bauerschmitz, G.; Hemmi, S.; Lavilla-Alonso, S.; Diaconu, I.; Guse, Kilian; Koski, A.;...
Cancer gene therapy2011Publicationer information ikon

Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1

Referentgranskad
Öppen tillgång
DOI
10.3390/cells10020246
Havunen, Riikka; Kalliokoski, Riikka; Siurala, Mikko; Sorsa, Suvi; Santos, Joao M.; Cervera-Carrasco...
Cells2021Publicationer information ikon

Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma

Referentgranskad
Öppen tillgång
DOI
10.1089/hum.2020.277
Milenova, Ioanna; Gonzalez, Marta Lopez; Quixabeira, Dafne C. A.; Santos, Joao Manuel; Cervera-Carra...
Human gene therapy2021Publicationer information ikon

An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage

Referentgranskad
Öppen tillgång
DOI
10.3389/fimmu.2023.1171083
Pakola, Santeri; Quixabeira, Dafne C. A.; Kudling, Tatiana V.; Clubb, James H. A.; Grönberg-Vähä-Kos...
Frontiers in immunology2023Publicationer information ikon

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression

Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2022.2096572
Kudling, Tatiana V.; Clubb, James H. A.; Quixabeira, Dafne C. A.; Santos, Joao M.; Havunen, Riikka; ...
Oncoimmunology2022Publicationer information ikon

Oncolytic adenovirus for treatment of malignant ascites

Öppen tillgång
DOI
10.1016/j.omto.2022.07.010
Hemminki, Akseli; Heiniö, Camilla
Molecular therapy : oncolytics2022

Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition

Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2020.1761229
2020

Oncolytic Adenoviruses for Cancer Therapy

Referentgranskad
Öppen tillgång
DOI
10.3390/ijms22052517
2021

Selective replication of miR-145-regulated oncolytic adenovirus in MCF-7 breast cancer cells

Referentgranskad
DOI
10.2217/fvl-2016-0069
2016

Mechanistic insights into oncolytic adenovirus therapy

Öppen tillgång
2023

Oncolytic adenovirus based on serotype 3

Referentgranskad
DOI
10.1038/cgt.2010.79
2011

Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1

Referentgranskad
Öppen tillgång
DOI
10.3390/cells10020246
2021

Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma

Referentgranskad
Öppen tillgång
DOI
10.1089/hum.2020.277
2021

An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage

Referentgranskad
Öppen tillgång
DOI
10.3389/fimmu.2023.1171083
2023

Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression

Referentgranskad
Öppen tillgång
DOI
10.1080/2162402X.2022.2096572
2022

Oncolytic adenovirus for treatment of malignant ascites

Öppen tillgång
DOI
10.1016/j.omto.2022.07.010
2022